Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Sanofi Moves Quickly to Reinforce Its Future Pipeline
Date 19 December 2025

Sanofi Moves Quickly to Reinforce Its Future Pipeline

Announcement Sanofi Moves Quickly to Reinforce Its Future Pipeline After a tough week marked by a disappointing multiple sclerosis (MS) trial result, Sanofi has moved decisively to strengthen its lo...

SK Capital cracked a business to maintain and strengthen its financial presence and drive growth and expansion
Date 18 December 2025

SK Capital cracked a business to maintain and strengthen its financial presence and drive growth and expansion

Announcement SK Capital Partners, LP, a well-known New York-based private investment entity focused on the life sciences, ingredients sectors and speciality materials, has declared that its syndicate...

Pharmanovia's entry with catumaxomab in Germany
Date 18 December 2025

Pharmanovia's entry with catumaxomab in Germany

Announcement Pharmanovia, a leading popular pharmaceutical company that markets the novel speciality drugs and the trusted developed medicines, has now introduced its Korjuny (Catumaxomab) in Germany...

Cencora's business move to expand solutions for the Oncology community
Date 18 December 2025

Cencora's business move to expand solutions for the Oncology community

Announcement Cencora, Inc. has inked a definitive, worthy deal to acquire most of the outstanding equity interests that are not yet owned by Cencora in OneOncology’s space. The OneOncology is a...

Immunome's convincing results to serve relief to Desmoid Tumor patients
Date 18 December 2025

Immunome's convincing results to serve relief to Desmoid Tumor patients

Announcement Immunome, Inc., a leading biotechnology company dedicated to establishing and introducing excellent, first-in-class, and best-in-class focused cancer therapies, has announced robust, pos...

First Human trial on Proprietary BMB18 Strain
Date 17 December 2025

First Human trial on Proprietary BMB18 Strain

The first human clinical trial on proprietary probiotic strain Lactobacillus plantarum BMB1 with the Australian and New Zealand Clinical Trials registry was registered and submitted with ethics approv...

Second FDA Approval for Neuren's Trofinetide
Date 17 December 2025

Second FDA Approval for Neuren's Trofinetide

With the launch of trodinetide’s formulation, Neuren has achieved its second FDA approval: In December 2025, Neuren Pharmaceuticals announced a milestone achievement with the launch of trodinet...

Japan's Initiatives to Boost Healthcare Services in Mount Lebanon
Date 17 December 2025

Japan's Initiatives to Boost Healthcare Services in Mount Lebanon

Introduction: Ambassador MAGOSHI Masayuki has unveiled Japan’s strong step toward supporting the recovery of the health sector in Lebanon as well as underscoring the initiatives to offer the re...

Astellas and Autobahn inked the deal to boost the Academic exploratory to introduce new drugs
Date 16 December 2025

Astellas and Autobahn inked the deal to boost the Academic exploratory to introduce new drugs

Announcement Autobahn Labs, a leading venture studio focused on the transition of potent academic science to noteworthy business strategic drug development and exploratory programs, proudly announce...

Mabylon AG's lands into the new trial for Peanut Allergy
Date 16 December 2025

Mabylon AG's lands into the new trial for Peanut Allergy

Announcement Mabylon AG is a known champion in the high-throughput discovery, establishment and engineering of human-inspired antibodies for the solution of inflammation, allergies and neurodegenera...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.